Agilent, Chungnam National University Tackle New Initiatives in Glycomics Research | GenomeWeb

NEW YORK (GenomeWeb News) – Building on an existing relationship, Agilent Technologies and Chungnam National University in South Korea today announced new initiatives in the area of glycomics.

The new research will aim to develop new biomarkers and new therapeutic antibodies against diseases such as cancer, they said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.